Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2019-07-09 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Trading Update
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated July 9, 2019. It explicitly states that the information constitutes 'inside information' under MAR and is being published via the 'Regulatory Information Service' (RNS). The content is an 'unaudited trading update' for the 12 months ended June 30, 2019, providing key financial highlights (revenue, cash position) and operational progress updates (WHO qualification, DoD sales). This format—a brief, timely announcement of key performance indicators outside of a full statutory report—is characteristic of an Earnings Release (ER). Although it is distributed via RNS, the primary function is to release earnings information, making ER the most specific classification. It is not a full 10-K, nor is it just an announcement of a report (RPA), as it contains the actual data.
2019-07-09 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is explicitly marked with an 'RNS Number' and contains the header 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the grant of share options to senior management (CEO, CFO, etc.) and cites Article 19(3) of the EU Market Abuse Regulation. This structure perfectly matches the definition of insider trading/director dealing disclosures, which corresponds to the 'Director's Dealing' category (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2019-04-05 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Results for the six-month period to 31 December 2018' and contains detailed financial statements, management discussion and analysis, and operational highlights for Genedrive PLC. It is a comprehensive report covering a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2019
2019-03-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 2894N' and contains the standard format for a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. The presence of the RNS identifier and the nature of the content (reporting voting rights changes) confirms this classification. It is not a full report (like 10-K or IR), but a specific regulatory disclosure.
2019-01-16 English
Trading update
Earnings Release Classification · 1% confidence The document begins with an 'RNS Number' and a release date, indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content is titled 'Trading Update' and provides an 'unaudited update for the six month period ended 31 December 2018,' detailing revenue, orders, registrations, and cash position. This is a concise, periodic update on operational and financial highlights, not the full comprehensive report (which would be an IR or 10-K). Since it is a formal, periodic update released through an official regulatory channel (RNS) that provides key financial highlights before the full report (which is scheduled for March 28, 2019), it fits best under the Earnings Release (ER) category. Although it is distributed via RNS, the specific content type is an earnings/trading update. H1 2019
2019-01-15 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is an announcement regarding the 'Result of AGM' (Annual General Meeting) for Genedrive plc. It confirms that 'all resolutions proposed were duly passed' at the AGM held on December 31, 2018. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, or in this case, the results thereof. Although it is a short announcement, the content is specific to the AGM outcome, making AGM-R a better fit than a general RPA or RNS.
2018-12-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.